Jim Zarroli

Jim Zarroli is an NPR correspondent based in New York. He covers economics and business news.

Over the years, he has reported on recessions and booms, crashes and rallies, and a long string of tax dodgers, insider traders, and Ponzi schemers. Most recently, he has focused on trade and the job market. He also worked as part of a team covering President Trump's business interests.

Before moving into his current role, Zarroli served as a New York-based general assignment reporter for NPR News. While in this position, he reported from the United Nations and was also involved in NPR's coverage of Hurricane Katrina, the London transit bombings, and the Fukushima earthquake.

Before joining NPR in 1996, Zarroli worked for the Pittsburgh Press and wrote for various print publications.

He lives in Manhattan, loves to read, and is a devoted (but not at all fast) runner.

Zarroli grew up in Wilmington, Delaware, in a family of six kids and graduated from Pennsylvania State University.

Updated at 4:20 p.m. ET

Not even the pandemic could keep the Dow from breaking a major milestone: the 30,000-point barrier.

The Dow Jones Industrial Average powered past 30,000 for the first time Tuesday after President Trump allowed the transition process to begin, even as he has yet to concede.

Loading...

Copyright 2020 NPR. To see more, visit https://www.npr.org.

AILSA CHANG, HOST:

President Trump's slash-and-burn rhetoric against China may have brought few lasting economic benefits so far, but it has succeeded in one fundamental way: No administration can now afford to play nice with the United States' biggest rival.

Trump made hostility toward China a centerpiece of his "America First" trade agenda, launching bitter attacks against Beijing's policies and setting off a trade war by slapping tariffs on two-thirds of Chinese imports.

Copyright 2020 NPR. To see more, visit https://www.npr.org.

ARI SHAPIRO, HOST:

Updated at 4:35 p.m. ET

Euphoria broke out Monday on Wall Street after promising news of a vaccine trial provided a major dose of hope for the global economy.

The powerful rally was sparked after Pfizer and its partner BioNTech said the experimental COVID-19 vaccine was more than 90% effective.

Pages